Satellos Bioscience share price logo

Satellos Bioscience

NASDAQ: MSLE

$9.30

-0.06

(-0.64%)

Live

as on

Satellos Bioscience Stock Performance

as on September 18, 2026 at 1:00 am IST

  • Day's Low

    Day's High

    $9.19
    $9.66
    downward going graph

    1.18%

    Downside

    3.87%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Satellos Bioscience share price movements today

Previous Close
$9.36
Open
$9.50
Volume
258.7K
Market Cap
$198.6M
Day's Low - High
$9.19 - $9.66

Satellos Bioscience Historical Returns

1 Month Return
-6.44 %
3 Month Return
+ 58.97 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Satellos Bioscience Stock Fundamentals & Key Indicators

Check Satellos Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$198.6M

EPS (TTM)

-2.358

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-70.45%

Satellos Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Satellos Bioscience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Satellos Bioscience image
Satellos Bioscience
StrongBuy$198.6MNANA0.00%0.00%
Revolution Medicines image
Revolution Medicines
BUY$43.9B527.35%NA0.00%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.4B172.58%29.7186.04%0.00%
Moderna image
Moderna
BUY$57.4B-66.14%-18.02-12.57%0.00%
Regeneron image
Regeneron
BUY$81.7B18.83%18.4884.86%0.48%

Analyst Recommendation on Satellos Bioscience Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Satellos Bioscience. Average target price of $25.75

Indian Investors' Interest in Satellos Bioscience Stock

Search interest for Satellos Bioscience Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-42% versus previous 30 day period

Satellos Bioscience Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
Operating Income
-5
-4
-6
-6
-5
-7
-10
-11
EBITDA
-5
-3
-6
-6
-5
-7
-10
-11
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
0
0
0
-
0
-
0
0
Income Before Tax
-8
-3
-6
-5
-5
-7
-9
-11
Income Tax Expense
-
-
0
0
0
0
0
0
Net Income
-8
-2
-6
-5
-5
-7
-9
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
Gross Profit
0
-3
0
0
0
Operating Income
-6
-8
-11
-19
-26
EBITDA
-4
-8
-11
-19
-26
Interest Expense
0
-
0
-
-
Depreciation
0
0
0
0
0
Income Before Tax
-15
-11
-11
-19
-24
Income Tax Expense
0
0
-
-
0
Net Income
-12
-11
-8
-13
-24
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Satellos Bioscience Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-8
-3
-6
-5
-5
-7
-9
-11
Operating Cash Flow
-5
-4
-7
-7
-4
-4
-7
-9
-7
Investing Cash Flow
2
17
-11
-
8
-15
-2
-32
-3
Financing Cash Flow
0
0
37
0
1
0
0
51
0
Change in Cash
-3
13
32
-7
5
-18
-9
8
-11

Satellos Bioscience Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-1
-1
-1
-12
-8
-15
-19
-24
Operating Cash Flow
-1
-1
-2
-1
-3
-5
-14
-17
-23
Investing Cash Flow
0
0
0
-
1
0
-17
4
-9
Financing Cash Flow
-
-
3
1
5
2
50
37
2
Change in Cash
0
-1
1
0
3
-1
21
24
-30

Mutual Funds that own Satellos Bioscience Stock

Check out the Mutual Funds with significant holdings in Satellos Bioscience.

Funds
Holdings
Shares Held
Franklin Strategic Series
1.617788%
343237

Global Institutional Holdings in Satellos Bioscience

Funds
Holdings
Michael Rockefeller
2.36%

Satellos Bioscience News & Key Events

  • img

    Today's Timeline - 09 September

    Wed, 04:46 PM

    -

    Satellos announces INN 'forazapadin' for SAT-3247, supporting regulatory submissions for Duchenne muscular dystrophy.

Insights on Satellos Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, MSLE stock has moved up by 59.0%

About Satellos Bioscience

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
OrganisationSatellos Bioscience
HeadquartersRoyal Bank Plaza, Toronto, ON, Canada, M5J 2J1
IndustryBiotechnology
CEOMr. Francis Gleeson B.B.A. M.B.A
E-voting on sharesClick here to vote

Key Management of Satellos Bioscience

Name

Title

Dr. Wildon Farwell M.D., M.P.H.

Chief Medical Officer

Mr. J. Robert Hall CFA

Senior Vice President of Finance & Administration

Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.

Strategic Advisor

Mr. Warren Whitehead C.M.A., CPA

Head of Corporate Strategy

Ms. Desiree Chan

Chief of Staff

Mr. Francis Gleeson B.B.A. M.B.A

Co-Founder, CEO, President & Director

Dr. Philip Lambert M.A., Ph.D.

Chief Scientific Officer

Dr. Ryan Mitchell Ph.D.

Senior VP & Head of Corporate Development

Ms. Elizabeth Williams C.A., CPA

CFO & Corporate Secretary

Dr. Michael A. Rudnicki Ph.D.

Co-Founder & Chief Discovery Officer

FAQs

What is Satellos Bioscience share price today?

Satellos Bioscience share price today is $9.30 as on . Satellos Bioscience share today touched a day high of $9.66 and a low of $9.19.

What is the 52 week high and 52 week low for Satellos Bioscience share?

Satellos Bioscience share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Satellos Bioscience stock price today i.e. is trending at $9.30,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Satellos Bioscience's market capitalisation today?

Satellos Bioscience market capitalisation is $0.00T as on .

How to invest in Satellos Bioscience Stock (MSLE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Satellos Bioscience on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Satellos Bioscience Shares that will get you 0.1613 shares as per Satellos Bioscience share price of $9.30 per share as on September 17, 2026 at 7:30 pm IST.

What is the minimum amount required to buy Satellos Bioscience Stock (MSLE) from India?

Indian investors can start investing in Satellos Bioscience (MSLE) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Satellos Bioscience stock (as per the Rupee-Dollar exchange rate as on ). Based on Satellos Bioscience share’s latest price of $9.30 as on September 17, 2026 at 7:30 pm IST, you will get 1.0753 shares of Satellos Bioscience. Learn more about fractional shares .